In Vivo Expansion of CAR T Cells and its Association with Safety and Efficacy in Patients Treated with Tisagenlecleucel

Time: 1:45 pm
day: Day Two


• Understanding in vivo expansion of CAR T cells

• Correlation of in vivo expansion with efficacy and safety endpoints such as cytokine release syndrome (CRS) and neurological events

• Exploring trends across indications (leukaemia and lymphoma)